Brief by Shorts91 Newsdesk / 07:02pm on 31 Jan 2024,Wednesday Tech Today
Cedars-Sinai Medical Center introduces a breakthrough 'heart-on-a-chip' model, utilizing mature heart cells derived from human-induced pluripotent stem cells. This miniature, lab-grown heart addresses cardiac risks associated with certain cancer therapies. With a beating rate of 60 beats per minute, resembling the human rhythm, the chip provides an ethical environment to test cancer drugs, minimizing potential heart damage. The innovation, reducing reliance on animal models, marks a significant step in evaluating and preventing cancer therapy-induced cardiotoxicity.
